Charlebois ED - Search Results

1

Are untimed antiretroviral drug levels useful predictors of adherence behavior?

Liechty CA, Alexander CS, Harrigan PR, Guzman JD, Charlebois ED, Moss AR, Bangsberg DR. Liechty CA, et al. Among authors: charlebois ed. AIDS. 2004 Jan 2;18(1):127-9. doi: 10.1097/00002030-200401020-00017. AIDS. 2004. PMID: 15090840

2

Differences in time from HIV seroconversion to CD4+ lymphocyte end-points and AIDS in cohorts of homosexual men.

Veugelers PJ, Schechter MT, Tindall B, Moss AR, Page KA, Craib KJ, Cooper DA, Coutinho RA, Charlebois E, Winkelstein W Jr, et al. Veugelers PJ, et al. AIDS. 1993 Oct;7(10):1325-9. doi: 10.1097/00002030-199310000-00004. AIDS. 1993. PMID: 7903540

3

Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993.

Osmond D, Charlebois E, Lang W, Shiboski S, Moss A. Osmond D, et al. JAMA. 1994 Apr 13;271(14):1083-7. JAMA. 1994. PMID: 7908703

4

Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men.

Osmond DH, Charlebois E, Sheppard HW, Page K, Winkelstein W, Moss AR, Reingold A. Osmond DH, et al. J Infect Dis. 1993 Jan;167(1):66-71. doi: 10.1093/infdis/167.1.66. J Infect Dis. 1993. PMID: 8418184

5

Bias in observational studies of treatment.

Osmond DH, Charlebois E, Moss AR. Osmond DH, et al. Ann Intern Med. 1996 Dec 1;125(11):941. doi: 10.7326/0003-4819-125-11-199612010-00024. Ann Intern Med. 1996. PMID: 8967684 No abstract available.

6

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A. Bangsberg DR, et al. Among authors: charlebois ed. AIDS. 2000 Mar 10;14(4):357-66. doi: 10.1097/00002030-200003100-00008. AIDS. 2000. PMID: 10770537

7

Provider assessment of adherence to HIV antiretroviral therapy.

Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, Moss A. Bangsberg DR, et al. Among authors: charlebois ed. J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):435-42. doi: 10.1097/00126334-200104150-00005. J Acquir Immune Defic Syndr. 2001. PMID: 11391162

8

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A. Bangsberg DR, et al. Among authors: charlebois ed. AIDS. 2001 Jun 15;15(9):1181-3. doi: 10.1097/00002030-200106150-00015. AIDS. 2001. PMID: 11416722 No abstract available.

9

Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco.

Charlebois ED, Bangsberg DR, Moss NJ, Moore MR, Moss AR, Chambers HF, Perdreau-Remington F. Charlebois ED, et al. Clin Infect Dis. 2002 Feb 15;34(4):425-33. doi: 10.1086/338069. Epub 2002 Jan 2. Clin Infect Dis. 2002. PMID: 11797167

10

Epidemiology of vancomycin-resistant Enterococcus faecium under a selective isolation policy at an urban county hospital.

Winston LG, Bangsberg DR, Chambers HF 3rd, Felt SC, Rosen JI, Charlebois ED, Wong M, Steele L, Gerberding JL, Perdreau-Remington F. Winston LG, et al. Among authors: charlebois ed. Am J Infect Control. 2002 Nov;30(7):400-6. doi: 10.1067/mic.2002.122647. Am J Infect Control. 2002. PMID: 12410216

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters